Bookmark and Sharºe


1: Gac Med Mex. 1993 May-Jun;129(3):201-5.
Tratamiento de la escabiasis con ivermectina por via oral.
Macotela-Ruiz, E; Pena-Gonzalez, G;
Servicio de Dermatologia y Micologia medica, Hospital de Especialidades. Centro Medico Nacional Siglo XXI, IMSS, Mexico, D.F.
To evaluate the efficacy and safety of a single 200 mcg/Kg dose of ivermectine as compared with placebo in the treatment of scabies was settled. Fifty five patients with the diagnosis of scabies were randomized to a single oral dose of ivermectine or placebo. The study informed that 26 (79.3%) patients were cured with ivermectine on their first follow-up visit, as compared to only four (16%) in the placebo group (X2 = 77.07, p < 0.001). Overall, 37 of 50 (74%) patients treated with ivermectine cured, as compared to only four of 26 (16%) treated with placebo, this difference was still significant (X2 = 23.66, p < 0.001). We concluded that ivermectine is a safe and effective treatment for scabies.
  • Femenino
  • Humanos
  • Masculino
  • Niño
  • Adultos
  • Adolescentes
  • Administración Oral
  • Placebos
  • Metodo Doble Ciego
  • Distribución de Chi-Cuadrado
  • Ivermectina (administration & dosage, adverse effects)
  • Escabiosis (drug therapy, epidemiology)

Pubgle

Buscador de Guías de Práctica Clínica

Enciclopedia Médica

Alerta Bibliográfica